Principia Biopharma Inc. IPO Research Information

Principia Biopharma Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Principia Biopharma Inc. , and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Principia Biopharma Inc.	PRNB - NASDAQ	$15.00-$17.00	$17.00	$25.66	6.3 million	9/14/2018
Underwriter(s): BofA Merrill Lynch, Leerink, Wells Fargo
Co-Manager(s): Baird
Industry: Health Care
Filing(s): Filed 2018-08-17 Terms Added 2018-01-01 Terms Changed 2018-09-13

Principia Biopharma Inc. Quote & Chart - Click for current quote - PRNB

About Principia Biopharma Inc. (adapted from Principia Biopharma Inc. prospectus):
They are a clinical-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with significant unmet medical needs in immunology and oncology.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "PRNB" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.